APP and Alzheimer disease: In AD mouse models immunization with aggregated β-amyloid 1–42 peptide reduced cerebral β-amyloid deposition, neuritic dystrophy and gliosis in amyloid precursor transgenic (APP-tg) mice [21]–[23] and also improved cognition [24],[25].